Back

FIDELITY Analysis: finerenone in mild-to-severe chronic kidney disease and type 2 diabetes - Part 1

28 August 2021 (17:42 - 17:46)
Organised by:
Congress Presentation Part of: Hot Line - FIGARO-DKD / FIDELITY Analysis Pharmacology and Pharmacotherapy ESC Premium Access ESC Congress 2021 - The Digital Experience

5 More presentations in this session

Presentation thumbnail
FIGARO-DKD: finerenone in patients with chronic kidney disease and type 2 diabetes
Professor B. Pitt (Ann Arbor, US)
Slides Video
Presentation thumbnail
FIGARO-DKD - Discussant review.
Associate Professor K. Damman (Groningen, NL)
Slides Video
Presentation thumbnail
FIDELITY Analysis: finerenone in mild-to-severe chronic kidney disease and type 2 diabetes
Professor G. Filippatos (Athens, GR)
Slides Video
Presentation thumbnail
FIDELITY Analysis - Discussant review.
Professor C. Baigent (Oxford, GB)
Slides Video
Presentation thumbnail
FIGARO-DKD / FIDELITY Analysis - Panel discussion.

Access the full session

Session thumbnail
Hot Line - FIGARO-DKD / FIDELITY Analysis
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

28 August 2021 17:42 CET
You may be interested in
thumbnail
Congress Presentation
Dynamics of indicators of central hemodynamics and arterial wall rigidity during the background of combination therapy with amlodipine/ valsartan in patients with arterial hypertension
thumbnail
Congress Session
Challenges in hypertension management
thumbnail
Congress Session
Optimal management of chronic coronary syndromes: putting the evidence into practice

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources